What is the incidence of arterial puncture during transperineal prostate biopsy and how should it be managed?

Arterial Puncture During Transperineal Prostate Biopsy: Incidence and Management

Arterial puncture during transperineal prostate biopsy is an extremely rare complication that is not specifically quantified in standard complication profiles, but when it occurs, it should be managed with immediate pressure, hemodynamic monitoring, and consideration for selective arterial embolization if bleeding persists.

Incidence of Arterial Injury

The available guideline evidence does not provide specific incidence rates for arterial puncture during transperineal prostate biopsy. The major guidelines 1 describe the most common complications as:

• Hematuria, hematospermia, and hematochezia (occurring in the majority of patients, typically self-limited within 3-14 days)
• Severe bleeding, prostatitis, sepsis, urinary retention, and vasovagal reactions (occurring in less than 5% of cases)

However, recent case reports reveal that arterial injury, while rare, can occur with serious consequences:

• Urethral corpus cavernosum pseudoaneurysm has been documented 2, requiring multidisciplinary management
• Subcutaneous hematomas involving the lower abdomen and perineum have been reported 3, managed successfully with prostatic artery angiography and superselective embolization
• Intraperitoneal bleeding from presumed arterial branch injury (likely inferior vesical artery branches) has occurred 4, 5, particularly in patients with prior prostate procedures

Clinical Recognition

Arterial puncture should be suspected when:

• Immediate or early postoperative hypotension develops (within hours of the procedure)
• Rapid hemoglobin/hematocrit drop occurs despite initial stability
• Expanding perineal, scrotal, or lower abdominal hematoma is visible or palpable
• Persistent bleeding that doesn't respond to initial conservative measures
• Hemodynamic instability requiring vasopressor support or blood transfusion

Management Algorithm

Immediate Management (First 1-2 Hours)

1. Apply direct perineal pressure to the biopsy site
2. Establish IV access and begin fluid resuscitation
3. Serial hemoglobin checks every 2-4 hours initially
4. Continuous hemodynamic monitoring (blood pressure, heart rate)
5. Hold all anticoagulant/antiplatelet agents if previously continued 6

If Bleeding Persists or Patient Destabilizes

1. Obtain urgent CT angiography of the pelvis to identify:

   • Active arterial extravasation
   • Hematoma location and size
   • Involvement of prostatic, inferior vesical, or pudendal arteries

2. Consult interventional radiology immediately for:

   • Superselective prostatic artery embolization 3 - this is the preferred first-line intervention
   • Embolization of specific bleeding vessels identified on angiography

3. Blood product support:

   • Transfuse for hemoglobin <7-8 g/dL or ongoing hemodynamic instability
   • Consider fresh frozen plasma if coagulopathic

Refractory Cases

If embolization fails or is not available:

• Surgical exploration may be required 7
• In patients with confirmed prostate cancer, emergency radical prostatectomy has been successfully performed as both hemostatic and definitive oncologic treatment 7

Prevention Strategies

Based on guideline recommendations 1, 8:

• Discontinue NSAIDs 7-10 days before biopsy to reduce bleeding risk

• For patients on anticoagulation: The transperineal approach may actually be safer than transrectal 9, but consider:

  • Holding warfarin 3-5 days pre-procedure (bridge if high thrombotic risk)
  • Holding NOACs 2-5 days depending on bleeding risk
  • Recent evidence suggests continuation of antiplatelet therapy under caudal anesthesia may be safe 6, though this requires careful patient selection

• Use ultrasound guidance carefully to avoid anterior prostatic vessels

• Consider smaller gauge needles when feasible

• Avoid excessive passes through the same tract

Key Clinical Pitfalls

1. Delayed presentation: Arterial bleeding may not manifest immediately; patients can deteriorate hours after discharge 5
2. Underestimating hematoma size: Perineal and retroperitoneal hematomas can be anatomically concealed 3
3. Prior prostate procedures: Patients with previous TURP or focal therapy have altered anatomy that may increase risk 4, 5
4. Assuming self-limitation: Unlike typical post-biopsy bleeding, arterial injury requires active intervention

Comparative Safety Note

The transperineal approach has demonstrated lower infection rates (near-zero sepsis rates in recent studies 10) compared to transrectal biopsy, and may have better sensitivity for anterior tumors 9. However, it carries a higher risk of urinary retention 10 and these rare but serious vascular complications must be recognized promptly.